Neurological manifestations and neuroimaging findings in patients with SARS-CoV2—a systematic review
Authors:
- Nikita MohanNMNikita Mohan
- Muhammad Ali FayyazMFMuhammad Ali Fayyaz
- Christopher del RioCRChristopher del Rio
- Navpreet Kaur Rajinder Singh KhuranaNKNavpreet Kaur Rajinder Singh Khurana
- Sampada Sandip VaidyaSVSampada Sandip Vaidya
- Esteban SalazarESEsteban Salazar
- John JoyceJJJohn Joyce
- Amrat Ayaz AliAAAmrat Ayaz Ali
Open Access
- 2 June 2021
- journal article
- review article
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 57 (1) , 1-19
Abstract
Background: The COVID-19 pandemic has drastically affected everyone in a hit or miss manner. Since it began, evidence of the neuro-invasive potential of the virus has been intensifying significantly. Several pathways have been hypothesized to elucidate the neurotropic nature of SARS-CoV2. It is the need of the hour to collect vital information. Objective: To evaluate and correlate the neuro-radiological and neurological manifestations in patients diagnosed with SARS-CoV2. To identify neuro-invasive pathways of COVID infection. Methods: Relevant studies were identified through four databases—the Cochrane Library, PubMed, Science Direct, and Web of Science. These were searched using relevant keywords—“COVID-19,” “SARS-CoV2,” “neurological manifestations,” “neuroimaging,” “CT,” and “MRI.” Relevant articles were screened according to a pre-defined inclusion and exclusion criteria from December 2019 to August 2020. Results: Our review included a total of 63 full text publications with 584 patients, composed mainly of observational studies, case reports, and case series. The most common neurological manifestations associated with COVID-19 were altered mental status, stroke, and paralysis. About 17.85% patients who underwent neuroimaging were found to be having ischemic changes suggestive of a stroke. This was followed by hemorrhagic changes as the second most common finding. The most commonly involved vessel was the Middle Cerebral Artery. Besides stroke, we found that SARS-CoV2 could be the cause for new-onset seizures, Guillain-Barre Syndrome, encephalitis, and many other severe neurological diseases. Conclusion: The information that we have obtained so far will prove dynamic to healthcare providers working against the COVID-19 pandemic. It is necessary to be aware of these atypical neurological findings for the early diagnosis and treatment of COVID-19 infected patients. However, to completely understand the connection between SARS-CoV2 and the nervous system, further research is necessary.Keywords
This publication has 81 references indexed in Scilit:
- COVID-19 presenting as strokeBrain, Behavior, and Immunity, 2020
- Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019Journal of Medical Virology, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Emergency room neurology in times of COVID‐19: malignant ischaemic stroke and SARS‐CoV‐2 infectionEuropean Journal of Neurology, 2020
- A first case of meningitis/encephalitis associated with SARS-Coronavirus-2International Journal of Infectious Diseases, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4The Journal of Infectious Diseases, 2015
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2Journal of Virology, 2008
- Maturation and Localization of Macrophages and Microglia During Infection with a Neurotropic Murine CoronavirusBrain Pathology, 2007
- Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin systemAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007